{"id":9045,"date":"2025-11-26T12:00:00","date_gmt":"2025-11-26T11:00:00","guid":{"rendered":"https:\/\/hemerion.com\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\/"},"modified":"2026-01-14T17:47:07","modified_gmt":"2026-01-14T16:47:07","slug":"open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie","status":"publish","type":"post","link":"https:\/\/hemerion.com\/fr\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\/","title":{"rendered":"Open Scientific Board Meeting : Hemerion innove pour acc\u00e9l\u00e9rer la diffusion de sa technologie"},"content":{"rendered":"\n

\u00c0 l\u2019occasion de son 5e anniversaire, Hemerion a organis\u00e9 \u00e0 la Maison de la Chimie \u00e0 Paris un Conseil Scientifique exceptionnel, ouvert aux investisseurs et aux grands industriels de la MedTech et de la Pharma\/Biotech. L\u2019objectif de cet \u00e9v\u00e9nement \u00e9tait de d\u00e9voiler les derni\u00e8res avanc\u00e9es cliniques obtenues dans le glioblastome et d\u2019explorer le potentiel de la th\u00e9rapie combin\u00e9e Pentalafen \/ Heliance dans le traitement de plusieurs autres cancers majeurs. <\/strong><\/p>\n\n

Enfant du monde acad\u00e9mique et clinique, Hemerion a conserv\u00e9 depuis sa cr\u00e9ation une activit\u00e9 de R&D intense<\/a>, pour am\u00e9liorer ses technologies et leur trouver les applications les plus innovantes. \u00c0 l\u2019occasion de son 5e anniversaire, Hemerion a souhait\u00e9 ouvrir son conseil scientifique aux investisseurs et aux industriels : une occasion unique d\u2019explorer le potentiel de la th\u00e9rapie combin\u00e9e Pentalafen\u00ae \/ Heliance\u00ae<\/a> dans plusieurs indications oncologiques.<\/p>\n\n

Les avanc\u00e9es cliniques dans le traitement du glioblastome<\/h2>\n\n

La premi\u00e8re partie de la conf\u00e9rence a \u00e9t\u00e9 consacr\u00e9e aux r\u00e9sultats cliniques obtenus dans le traitement du glioblastome<\/a>, la forme la plus agressive de cancer du cerveau, pour laquelle Hemerion finalise actuellement un essai multicentrique de phase I\/II, en Europe et aux USA.<\/p>\n\n

Ces r\u00e9sultats ont \u00e9t\u00e9 largement d\u00e9taill\u00e9s par les deux neurochirurgiens pionniers de la technologie : le Pr Reyns du CHU de Lille et le Pr Hadjipanayis, de l\u2019UPMC.<\/p>\n\n

Le Dr. Everardo Saad, r\u00e9cemment nomm\u00e9 Medical Director d\u2019Hemerion<\/a>, a ensuite pr\u00e9sent\u00e9 le design de la phase clinique pivot, destin\u00e9e \u00e0 motiver les autorisations de mise sur le march\u00e9 aupr\u00e8s de la FDA et de l\u2019EMA. Pr\u00e9vu au premier semestre 2026, son lancement pr\u00e9figure une commercialisation de la th\u00e9rapie sur les deux continents d\u00e8s 2029.<\/p>\n\n

Quelle place pour la technologie Hemerion dans le standard de soins des cancers du cerveau ?<\/h2>\n\n

Men\u00e9e en 30 minutes au cours de l\u2019intervention de r\u00e9section tumorale, la th\u00e9rapie Pentalafen \/ Heliance s\u2019int\u00e8gre parfaitement dans le standard de soin actuel en compl\u00e9ment de chimioth\u00e9rapie et de la radioth\u00e9rapie. Les \u00e9tudes cliniques montrent de plus qu\u2019elle n\u2019a aucun impact n\u00e9gatif sur les cellules saines. <\/p>\n\n

Ce conseil scientifique exceptionnel a permis d\u2019initier une r\u00e9flexion avec les soignants sur la place que pourrait prendre la technologie Hemerion par rapport \u00e0 la radioth\u00e9rapie, dont les effets secondaires impactent s\u00e9v\u00e8rement la qualit\u00e9 de vie des patients.<\/p>\n\n

Pipeline : de nouvelles indications en vue pour la th\u00e9rapie Pentalafen\u00ae \/ Heliance\u00ae<\/h2>\n\n

Plusieurs interventions ont ensuite explor\u00e9 le potentiel de la th\u00e9rapie Heliance \/ Pentalafen dans le traitement d\u2019autres tumeurs trait\u00e9es par la chirurgie.<\/p>\n\n

Anim\u00e9s par M\u00e9lanie Rose, r\u00e9cemment nomm\u00e9e \u00e0 la t\u00eate de l\u2019innovation scientifique d\u2019Hemerion<\/a>, ces \u00e9changes ont donn\u00e9 la parole \u00e0 plusieurs cliniciens et scientifiques de niveau international.<\/p>\n\n

Comment acc\u00e9l\u00e9rer l\u2019innovation en sant\u00e9 au service des patients ?<\/h2>\n\n

Pour cl\u00f4re ce conseil scientifique extraordinaire, Hemerion a r\u00e9uni un panel complet de leaders de la pharma et de la medtech autour d\u2019une question centrale : comment int\u00e9grer l\u2019innovation port\u00e9e par Hemerion dans un groupe industriel pour acc\u00e9l\u00e9rer la mise sur le march\u00e9 et la mise \u00e0 disposition des patients <\/p>\n\n

Un sujet majeur, face \u00e0 un v\u00e9ritable probl\u00e8me de sant\u00e9 publique, qui co\u00fbte la vie \u00e0 plusieurs milliers de patients dans le monde chaque ann\u00e9e.<\/p>\n\n

\n
\"Maximilien<\/figure>\n\n\n\n
\"Michael<\/figure>\n\n\n\n
\"Open<\/figure>\n\n\n\n
\"Open<\/figure>\n\n\n\n
\"Open<\/figure>\n\n\n\n
\"Open<\/figure>\n\n\n\n
\"Open<\/figure>\n\n\n\n
\"Open<\/figure>\n\n\n\n
\"Open<\/figure>\n\n\n\n
\"Open<\/figure>\n\n\n\n
\"Open<\/figure>\n\n\n\n
\"Open<\/figure>\n\n\n\n
\"Open<\/figure>\n\n\n\n
\"Open<\/figure>\n\n\n\n
\"Open<\/figure>\n\n\n\n
\"Open<\/figure>\n<\/figure>\n","protected":false},"excerpt":{"rendered":"

\u00c0 l\u2019occasion de son 5e anniversaire, Hemerion a organis\u00e9 \u00e0 la Maison de la Chimie \u00e0 Paris un Conseil Scientifique exceptionnel, ouvert aux investisseurs et aux grands industriels de la MedTech et de la Pharma\/Biotech. L\u2019objectif de cet \u00e9v\u00e9nement \u00e9tait de d\u00e9voiler les derni\u00e8res avanc\u00e9es cliniques obtenues dans le glioblastome et d\u2019explorer le potentiel de … <\/p>\n

Lire plus<\/a><\/p>\n","protected":false},"author":207845438,"featured_media":9044,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_crdt_document":"","jetpack_post_was_ever_published":false,"_jet_sm_ready_style":"","_jet_sm_style":"","_jet_sm_controls_values":"","_jet_sm_fonts_collection":"","_jet_sm_fonts_links":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[6342],"tags":[],"class_list":["post-9045","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites"],"yoast_head":"\nOpen Scientific Board Meeting : Hemerion innove pour acc\u00e9l\u00e9rer la diffusion de sa technologie - Hemerion<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hemerion.com\/fr\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Open Scientific Board Meeting : Hemerion innove pour acc\u00e9l\u00e9rer la diffusion de sa technologie - Hemerion\" \/>\n<meta property=\"og:description\" content=\"\u00c0 l\u2019occasion de son 5e anniversaire, Hemerion a organis\u00e9 \u00e0 la Maison de la Chimie \u00e0 Paris un Conseil Scientifique exceptionnel, ouvert aux investisseurs et aux grands industriels de la MedTech et de la Pharma\/Biotech. L\u2019objectif de cet \u00e9v\u00e9nement \u00e9tait de d\u00e9voiler les derni\u00e8res avanc\u00e9es cliniques obtenues dans le glioblastome et d\u2019explorer le potentiel de ... Lire plus\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hemerion.com\/fr\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\/\" \/>\n<meta property=\"og:site_name\" content=\"Hemerion\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-26T11:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-14T16:47:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hemerion.com\/wp-content\/uploads\/hemerion-open-scientific-board-meeting.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"1328\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Simon Delmotte\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HemerionTx\" \/>\n<meta name=\"twitter:site\" content=\"@HemerionTx\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Simon Delmotte\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\\\/\"},\"author\":{\"name\":\"Simon Delmotte\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#\\\/schema\\\/person\\\/ec5b45c7f7f52200ee5073ce247a86c7\"},\"headline\":\"Open Scientific Board Meeting : Hemerion innove pour acc\u00e9l\u00e9rer la diffusion de sa technologie\",\"datePublished\":\"2025-11-26T11:00:00+00:00\",\"dateModified\":\"2026-01-14T16:47:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\\\/\"},\"wordCount\":589,\"publisher\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/hemerion-open-scientific-board-meeting.jpg?fit=2000%2C1328&ssl=1\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\\\/\",\"url\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\\\/\",\"name\":\"Open Scientific Board Meeting : Hemerion innove pour acc\u00e9l\u00e9rer la diffusion de sa technologie - Hemerion\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/hemerion-open-scientific-board-meeting.jpg?fit=2000%2C1328&ssl=1\",\"datePublished\":\"2025-11-26T11:00:00+00:00\",\"dateModified\":\"2026-01-14T16:47:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/hemerion.com\\\/fr\\\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\\\/#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/hemerion-open-scientific-board-meeting.jpg?fit=2000%2C1328&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/hemerion-open-scientific-board-meeting.jpg?fit=2000%2C1328&ssl=1\",\"width\":2000,\"height\":1328,\"caption\":\"Maison de la Chimie \u00e0 Paris, o\u00f9 s'est tenue l'Open Scientifc Board Meeting d'Hemerion le 26 novembre 2025.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Open Scientific Board Meeting : Hemerion innove pour acc\u00e9l\u00e9rer la diffusion de sa technologie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/\",\"name\":\"Hemerion\",\"description\":\"Advancing cancer therapies at the speed of light\",\"publisher\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#organization\",\"name\":\"Hemerion\",\"url\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/hemerion-logo.png?fit=1581%2C460&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/hemerion-logo.png?fit=1581%2C460&ssl=1\",\"width\":1581,\"height\":460,\"caption\":\"Hemerion\"},\"image\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/HemerionTx\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hemerion-therapeutics\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCWwcUj-aSdo32OYwN5vjf8Q\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#\\\/schema\\\/person\\\/ec5b45c7f7f52200ee5073ce247a86c7\",\"name\":\"Simon Delmotte\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2f742e1ce87613e0ccca0877b0360f87beea918ba8e5efe3717e2c5285bfdc28?s=96&d=identicon&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2f742e1ce87613e0ccca0877b0360f87beea918ba8e5efe3717e2c5285bfdc28?s=96&d=identicon&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2f742e1ce87613e0ccca0877b0360f87beea918ba8e5efe3717e2c5285bfdc28?s=96&d=identicon&r=g\",\"caption\":\"Simon Delmotte\"},\"url\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/author\\\/simondelmotte\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Open Scientific Board Meeting : Hemerion innove pour acc\u00e9l\u00e9rer la diffusion de sa technologie - Hemerion","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hemerion.com\/fr\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\/","og_locale":"fr_FR","og_type":"article","og_title":"Open Scientific Board Meeting : Hemerion innove pour acc\u00e9l\u00e9rer la diffusion de sa technologie - Hemerion","og_description":"\u00c0 l\u2019occasion de son 5e anniversaire, Hemerion a organis\u00e9 \u00e0 la Maison de la Chimie \u00e0 Paris un Conseil Scientifique exceptionnel, ouvert aux investisseurs et aux grands industriels de la MedTech et de la Pharma\/Biotech. L\u2019objectif de cet \u00e9v\u00e9nement \u00e9tait de d\u00e9voiler les derni\u00e8res avanc\u00e9es cliniques obtenues dans le glioblastome et d\u2019explorer le potentiel de ... Lire plus","og_url":"https:\/\/hemerion.com\/fr\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\/","og_site_name":"Hemerion","article_published_time":"2025-11-26T11:00:00+00:00","article_modified_time":"2026-01-14T16:47:07+00:00","og_image":[{"width":2000,"height":1328,"url":"https:\/\/hemerion.com\/wp-content\/uploads\/hemerion-open-scientific-board-meeting.jpg","type":"image\/jpeg"}],"author":"Simon Delmotte","twitter_card":"summary_large_image","twitter_creator":"@HemerionTx","twitter_site":"@HemerionTx","twitter_misc":{"\u00c9crit par":"Simon Delmotte","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/hemerion.com\/fr\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\/#article","isPartOf":{"@id":"https:\/\/hemerion.com\/fr\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\/"},"author":{"name":"Simon Delmotte","@id":"https:\/\/hemerion.com\/fr\/#\/schema\/person\/ec5b45c7f7f52200ee5073ce247a86c7"},"headline":"Open Scientific Board Meeting : Hemerion innove pour acc\u00e9l\u00e9rer la diffusion de sa technologie","datePublished":"2025-11-26T11:00:00+00:00","dateModified":"2026-01-14T16:47:07+00:00","mainEntityOfPage":{"@id":"https:\/\/hemerion.com\/fr\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\/"},"wordCount":589,"publisher":{"@id":"https:\/\/hemerion.com\/fr\/#organization"},"image":{"@id":"https:\/\/hemerion.com\/fr\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-open-scientific-board-meeting.jpg?fit=2000%2C1328&ssl=1","articleSection":["Actualit\u00e9s"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/hemerion.com\/fr\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\/","url":"https:\/\/hemerion.com\/fr\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\/","name":"Open Scientific Board Meeting : Hemerion innove pour acc\u00e9l\u00e9rer la diffusion de sa technologie - Hemerion","isPartOf":{"@id":"https:\/\/hemerion.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/hemerion.com\/fr\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\/#primaryimage"},"image":{"@id":"https:\/\/hemerion.com\/fr\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-open-scientific-board-meeting.jpg?fit=2000%2C1328&ssl=1","datePublished":"2025-11-26T11:00:00+00:00","dateModified":"2026-01-14T16:47:07+00:00","breadcrumb":{"@id":"https:\/\/hemerion.com\/fr\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hemerion.com\/fr\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/hemerion.com\/fr\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\/#primaryimage","url":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-open-scientific-board-meeting.jpg?fit=2000%2C1328&ssl=1","contentUrl":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-open-scientific-board-meeting.jpg?fit=2000%2C1328&ssl=1","width":2000,"height":1328,"caption":"Maison de la Chimie \u00e0 Paris, o\u00f9 s'est tenue l'Open Scientifc Board Meeting d'Hemerion le 26 novembre 2025."},{"@type":"BreadcrumbList","@id":"https:\/\/hemerion.com\/fr\/open-scientific-board-meeting-hemerion-innove-pour-accelerer-la-diffusion-de-sa-technologie\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hemerion.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Open Scientific Board Meeting : Hemerion innove pour acc\u00e9l\u00e9rer la diffusion de sa technologie"}]},{"@type":"WebSite","@id":"https:\/\/hemerion.com\/fr\/#website","url":"https:\/\/hemerion.com\/fr\/","name":"Hemerion","description":"Advancing cancer therapies at the speed of light","publisher":{"@id":"https:\/\/hemerion.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hemerion.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/hemerion.com\/fr\/#organization","name":"Hemerion","url":"https:\/\/hemerion.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/hemerion.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-logo.png?fit=1581%2C460&ssl=1","contentUrl":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-logo.png?fit=1581%2C460&ssl=1","width":1581,"height":460,"caption":"Hemerion"},"image":{"@id":"https:\/\/hemerion.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/HemerionTx","https:\/\/www.linkedin.com\/company\/hemerion-therapeutics\/","https:\/\/www.youtube.com\/channel\/UCWwcUj-aSdo32OYwN5vjf8Q"]},{"@type":"Person","@id":"https:\/\/hemerion.com\/fr\/#\/schema\/person\/ec5b45c7f7f52200ee5073ce247a86c7","name":"Simon Delmotte","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/2f742e1ce87613e0ccca0877b0360f87beea918ba8e5efe3717e2c5285bfdc28?s=96&d=identicon&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2f742e1ce87613e0ccca0877b0360f87beea918ba8e5efe3717e2c5285bfdc28?s=96&d=identicon&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2f742e1ce87613e0ccca0877b0360f87beea918ba8e5efe3717e2c5285bfdc28?s=96&d=identicon&r=g","caption":"Simon Delmotte"},"url":"https:\/\/hemerion.com\/fr\/author\/simondelmotte\/"}]}},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-open-scientific-board-meeting.jpg?fit=2000%2C1328&ssl=1","jetpack_shortlink":"https:\/\/wp.me\/pd9WhZ-2lT","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/posts\/9045","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/users\/207845438"}],"replies":[{"embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/comments?post=9045"}],"version-history":[{"count":5,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/posts\/9045\/revisions"}],"predecessor-version":[{"id":9079,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/posts\/9045\/revisions\/9079"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/media\/9044"}],"wp:attachment":[{"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/media?parent=9045"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/categories?post=9045"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/tags?post=9045"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}